Be Mike Patton’s Co-Pilot
Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass
Read ArticleSign Up to Receive the Latest Trading Tips and News from Prosper
February 25, 2019
February 25, 2019
Zosano On the Launching Pad Again
Zosano Pharma Corp (ZSAN) shares were up over 23% today following news last week that the company reached its final milestone in its long-term safety study of Qtrypta for the acute treatment of migraine disease. The stock is still well below the 6.65 high price from February 21st, but we can now expect the stock […]
Read Article
February 22, 2019
Darker Days Ahead For Karyopharm Therapeutics?
Karyopharm Therapeutics (KPTI) shares were down sharply today after negative comments from the FDA regarding their drug application for Selinexor. The FDA noted that it doesn’t see the benefit of the drug with respect to its potential risks. This report was to be released later this month, but apparently was leaked today, causing the sharp […]
Read Article
February 21, 2019
No More Headaches For Zosana Pharma?
Zosano Pharma Corp (ZSAN) shares rose dramatically today due to the news that the company met the final milestones for its long-term safety study of Qtrypta, an acute treatment for migraine disease. The stock moved up over +180% on extremely high volume, with very little hesitation along the way. Here’s a recap.
Read Article
February 19, 2019
Block Chain Is Back!
RIOT Blockchain (RIOT) shares rose sharply today due to bullish trading in the cryptocurrency markets. RIOT made a name for itself (quite literally) in 2017 when it decided to abandon its previous business activities in the healthcare space and convert itself into a cryptocurrency mining operation. This decision essentially saved the company from sinking due […]
Read Article
February 15, 2019
Have A Seat With Mike Patton
Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass
Read Article
February 15, 2019
AcelRx Is Strong!
AcelRx Pharmaceuticals (ACRX) shares rose strongly in trading today. The company received initial coverage from Credit Suisse, with an outperform rating and $7 price target. ACRX recently received FDA approval in late 2018 for its powerful opioid DSUVIA. The company insists that it will tightly regulate the distribution and dosage so as to avoid patients […]
Read Article
February 14, 2019
Guardant Health Has A Couple Secret Admirers
Guardant Health Inc. (Ticker: GH) shares were up strongly starting at the middle of the session. The rise appears to be due to the disclosure of passive stakes in the company by at least two funds. Shares moved as high as $48.46 as of the time this content was created, a gain of nearly 12%. […]
Read Article
February 12, 2019
Axovant Sciences…So You Are Saying There’s A Chance
Axovant Sciences, LTD (AXON) shares had a brief spike in trading today, but gradually slid back to negative territory for the session. The company’s shares have been under consistent negative pressure since the second half of 2017, primarily due to persistent failures of the gene therapy treatments the company has researched. While the market is […]
Read Article
February 11, 2019
Take A Seat With Our Mike Patton
Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass
Read Article
